Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates
NCT00577642
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Zoledronic acid
Sponsor
Massachusetts General Hospital
Collaborators
[object Object]
[object Object]
[object Object]